Topic: atrial fibrillation
IRhythm’s ECG patch was able to improve atrial fibrillation diagnoses and lower numbers of ER visits by shifting patients to outpatient settings.
Canvassing more than 400,000 people in 8 months, Apple has finished an investigation of its smartwatch’s ability to detect irregular heart rhythms.
Medtronic has moved to buy EPIX Therapeutics and its RF cardiac ablation system with plans to build out its suite of heart arrhythmia treatments.
Apple and J&J are teaming up to see if the Apple Watch can help catch and diagnose seniors with atrial fibrillation earlier and faster than before.
The new Apple Watch’s electrocardiogram capability has gone live, available as a free software update that allows for wrist-based ECGs on the go.
The Forbion-led series C round sets Omeicos up to run a phase 2 trial of its small molecule analogue of a natural omega-3 fatty acid metabolite.
A tool called “polygenic risk scoring” could help physicians identify who faces a high risk of serious diseases.
Boston Scientific bought cardiac cryoablation devicemaker Cryterion, a company the medical device giant has invested in since its launch in 2016.
The takeover will give Philips a 3D cardiac imaging system to slot into its portfolio of interventional imaging technologies.
Apple has told participants in its heart study that their data will be used to seek FDA approval for an investigational device.